Quick Answer
MEDIFAST INC reported Diluted EPS of $1.70 per share (loss) for fiscal year 2025.
MEDIFAST INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.70 | -994.7% |
| 2024 | $0.19 | -97.9% |
| 2023 | $9.10 | -28.5% |
| 2022 | $12.73 | -8.4% |
| 2021 | $13.89 | +60.0% |
| 2020 | $8.68 | +35.0% |
| 2019 | $6.43 | +39.2% |
| 2018 | $4.62 | +101.7% |
| 2017 | $2.29 | +53.7% |
| 2016 | $1.49 | -10.2% |
| 2015 | $1.66 | +61.2% |
| 2014 | $1.03 | -40.5% |
| 2013 | $1.73 | +49.1% |
| 2012 | $1.16 | -11.5% |
| 2011 | $1.31 | -3.0% |
| 2010 | $1.35 | +75.3% |
| 2009 | $0.77 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.21 | -310.0% | -195.5% |
| June 30, 2025 | $0.22 | +129.3% | +414.3% |
| March 31, 2025 | -$0.07 | -109.2% | -170.0% |
| September 30, 2024 | $0.10 | -95.3% | +113.3% |
| June 30, 2024 | -$0.75 | -127.1% | -198.7% |
| March 31, 2024 | $0.76 | -79.3% | -64.2% |
| September 30, 2023 | $2.12 | -35.2% | -23.5% |
| June 30, 2023 | $2.77 | -19.0% | -24.5% |
- MEDIFAST INC showed a decrease of -994.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, MEDIFAST INC’s diluted eps has declined by 320.8% (from $0.77 per share to $1.70 per share (loss)).
- The most recent figure is from MEDIFAST INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: